Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.37

+0.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (5747)	2/26/2002 1:04:19 PM
From: Jibacoa	of 52153

Yes, it seems RAVEL has so far the best results, and JNJ should be able to get over its Nov.23 H of 60.97 I thought KOSP is going to have a hard time competing with the big boys in the field. It is probably a good product although it still reportedly has 7% drop-out. The product is just getting into the pharmacies and two months from approval is still too short time to tell. The stock seems to have found support at 10.5 The Biotechs seem to be acting better than the market today.<g> SEPR has found support at 36 and should retest the 47 level. RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next